Journals / Turkish journal of vascular surgery / 2021 / Cilt: 30 - Sayı: 3

Zone 2 landing at different aortic pathologies: Surgeon-modified fenestrated stent graft

Pages
249–253
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Durability is of great concern, and the most suitable treatment modality for zone 2 landing necessitates randomized-controlled studies and long-term durability issues.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The treatment of aortic pathologies is always challenging for vascular surgeons.
📊
Key Findings & Data:Herein, we present three different scenarios in zone 2 landing treated with surgeon-modified fenestrated stent graft (SMFSG).
💡
Conclusion & Impact:Durability is of great concern, and the most suitable treatment modality for zone 2 landing necessitates randomized-controlled studies and long-term durability issues.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

The treatment of aortic pathologies is always challenging for vascular surgeons. Currently, thoracic endovascular aortic repair (TEVAR) is the first treatment option for thoracic aortic pathologies. Left subclavian artery (LSA) coverage during TEVAR can be selectively done; however, revascularization is preferred to reduce the risk of neurological or ischemic complications according to current guidelines. The chimney technique, hybrid operations, back table or in situ fenestrations are assistive TEVAR techniques. Herein, we present three different scenarios in zone 2 landing treated with surgeon-modified fenestrated stent graft (SMFSG). The use of SMFSG for LSA revascularization during TEVAR is feasible, cost-effective, fast, and effective. Durability is of great concern, and the most suitable treatment modality for zone 2 landing necessitates randomized-controlled studies and long-term durability issues.

🔖

Cite This Article

ÜNAL, E. U., İŞCAN, H. Z., MAVİOĞLU, H. L., ÖZATİK, M. A. (2021). Zone 2 landing at different aortic pathologies: Surgeon-modified fenestrated stent graft. Turkish journal of vascular surgery, Cilt: 30 - Sayı: 3, 249–253. https://ajindex.com/articles/404263

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Schermerhorn ML, Jones DW. Management of descending thoracic aorta disease: evolving treatment paradigms in the TEVAR Era. Eur J Vasc Endovasc Surg 2017;53:1-3
  2. Canaud L, Morishita K, Gandet T, Sfeir J, Bommart S, Alric P, et al. Homemade fenestrated stent-graft for thoracic endovascular aortic repair of zone 2 aortic lesions. J Thorac Cardiovasc Surg 2018;155:488-93
  3. Shu C, Fan B, Luo M, Li Q, Fang K, Li M, et al. Endovascular treatment for aortic arch pathologies: chimney, on-the-table fenestration, and in-situ fenestration techniques. J Thorac Dis 2020;12:1437-48
  4. Zhang L, Wu MT, Zhu GL, Feng JX, Song C, Li HY, et al. Off-the-shelf devices for treatment of thoracic aortic diseases: midterm follow-up of TEVAR with chimneys or physician-made fenestrations. J Endovasc Ther 2020;27:132-42
  5. Küçüker A, Hıdıroğlu M, Çetin L, Kunt A, Sağlam F, Bayram H, et al. The results of carotid-subclavian bypass in a single institute. Damar Cer Derg 2013;22:285-91
  6. İşcan HZ, Ünal EU. Surgeon-modified fenestrated stent graft deployment in type B aortic dissection. Turk Gogus Kalp Dama 2021;29:285-9
  7. Kuo HS, Tsai KC, Chen JS. Endovascular aortic arch reconstruction with parallel grafts: a dilemma of excessive endograft oversizing. Acta Cardiol Sin 2020;36:351-9
  8. Rynio P, Kazimierczak A, Jedrzejczak T, Gutowski P. A 3-dimensional printed aortic arch template to facilitate the creation of physician-modified stent- grafts. J Endovasc Ther 2018;25:554-8
  9. Starnes BW. A surgeon's perspective regarding the regulatory, compliance, and legal issues involved with physician-modified devices. J Vasc Surg 2013;57:829-31.